- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy ; volume:17 ; number:1 ; day:16 ; month:5 ; year:2018 ; pages:1-10 ; date:12.2018
Molecular cancer ; 17, Heft 1 (16.5.2018), 1-10, 12.2018
- Creator
-
Pang, Yanyu
- Contributor
-
Hou, Xiaoyang
Yang, Chunsheng
Liu, Yanqun
Jiang, Guan
SpringerLink (Online service)
- DOI
-
10.1186/s12943-018-0840-y
- URN
-
urn:nbn:de:101:1-2018072217503190649672
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pang, Yanyu
- Hou, Xiaoyang
- Yang, Chunsheng
- Liu, Yanqun
- Jiang, Guan
- SpringerLink (Online service)
Other Objects (12)
Chimeric Antigen Receptor T-Cell Therapy
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
Chimeric Antigen Receptor T-Cell Therapy
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
Chimeric Antigen Receptor T-Cell Therapy
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice